Add to Favorites Newsroom RSS Share
Kansas City, KS USA

Our News on Newswise

BWP000B3.jpg

Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.
29-Jun-2018 11:05 AM EDT Add to Favorites

NikkiNollen.jpg

Researchers Evaluate Methods for Quitting Tobacco

Researchers at The University of Kansas Cancer Center have received a five-year National Institutes of Health R0-1 grant to compare and evaluate the efficacy of optimized versus non-optimized tobacco cessation approaches for African American smokers.
26-Jun-2018 4:35 PM EDT Add to Favorites

New Drug Combination Shows Promise in Treating Ovarian Cancer

Researchers at The University of Kansas Cancer Center have discovered a therapy combination that may be helpful in the treatment of certain types of ovarian cancer.
7-Jun-2018 4:00 PM EDT Add to Favorites

RoyJensen.jpg

The University of Kansas Cancer Center is joining forces with the nation’s top cancer centers to advocate for more HPV vaccinations

The University of Kansas Cancer Center is joining forces with a host of the nation’s top cancer centers to focus the spotlight on eliminating human papillomavirus (HPV)-related cancers in the United States.
7-Jun-2018 2:05 PM EDT Add to Favorites

ScottWeir.jpg

Anti-cancer agent Ciclopirox Prodrug’s first-in-human Clinical Trial to be presented at ASCO 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Society of Clinical Oncology (ASCO) annual meeting in...
1-Jun-2018 9:05 AM EDT Add to Favorites

KU Medical Center Receives FDA Clearance to Proceed with Phase 1 Trial in Graft-versus-Host Disease Patients

The University of Kansas Medical Center announced that the U.S. Food and Drug Administration (FDA) has cleared it to begin a first-in-human clinical trial of MSCTC-0010 in patients with de novo high-risk acute or steroid-refractory acute...
16-May-2018 10:05 AM EDT Add to Favorites

Fending Off Lymphedema Through Early Intervention

A study conducted by researchers at The University of Kansas Cancer Center has found that early, ongoing screening of lymphatic function and immediate patient-administered therapies are highly effective in improving outcomes for women at high risk...
10-May-2018 12:05 PM EDT Add to Favorites

SoperColor.jpg

Chip-Based Blood Test for Multiple Myeloma Could Help Make Bone Biopsies a Relic of the Past

A new University of Kansas research effort featured in the current edition of Integrative Biology has resulted in a low-cost, reliable blood test that uses a small plastic chip about the size of a credit card that can deliver the same diagnostic...
19-Apr-2018 11:05 AM EDT Add to Favorites


see all news

Our Experts on Newswise

Triple-Threat

Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT

KlempJennifer2008.jpg

Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT

JChien_Lawrence.jpg

Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

see all experts

Our YouTube Videos





Chat now!